tradingkey.logo

BioNexus Gene Lab Corp

BGLC
View Detailed Chart
5.365USD
+0.055+1.04%
Market hours ETQuotes delayed by 15 min
9.64MMarket Cap
LossP/E TTM

BioNexus Gene Lab Corp

5.365
+0.055+1.04%
Intraday
1m
30m
1h
D
W
M
D

Today

+1.04%

5 Days

+3.37%

1 Month

+1.42%

6 Months

+99.44%

Year to Date

+91.81%

1 Year

+41.63%

View Detailed Chart

Key Insights

The company's fundamentals are relatively very healthy. Its valuation is considered fairly valued,and institutional recognition is relatively high. Despite an average stock market performance, the company shows strong fundamentals. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

BioNexus Gene Lab Corp's Score

Industry at a Glance

Industry Ranking
222 / 407
Overall Ranking
429 / 4616
Industry
Biotechnology & Medical Research

Support & Resistance

No Data

Score Analysis

Current score
Previous score

Analyst Rating

Based on 0 analysts
--
Current Rating
--
Target Price
--
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

BioNexus Gene Lab Corp Highlights

StrengthsRisks
BioNexus Gene Lab Corporation is a Malaysia-based company, which provides ribonucleic acid (RNA)-based genomic diagnostics. The Company provides a molecular lab that is focused on the application of functional genomics to enable early detection of infectious diseases and cancers. The Company operates in the biochemical industry segment through its two Malaysian subsidiaries, MRNA Scientific Malaysia and Chemrex. MRNA Scientific Malaysia owns algorithm software, technology, and know-how related to the detection of common diseases through blood analysis which the Company uses in its business. The Company's non-invasive blood screening tests analyze changes in RNA to coronavirus, dengue, human immunodeficiency virus (HIV), human papillomavirus (HPV) and the risk potentiality of cancer diseases. Chemrex is a wholesaler of industrial chemicals for the manufacture of industrial, medical, appliance, aero, automotive, mechanical and electronic industries in Asean region.
Growing
The company is in a growing phase, with the latest annual income totaling USD 9.51M.
High Profit Growth
The company's net income leads the industry, with the latest annual income totaling USD 9.51M.
Fairly Valued
The company’s latest PE is -3.24, at a medium 3-year percentile range.
Institutional Selling
The latest institutional holdings are 9.56K shares, decreasing 63.72% quarter-over-quarter.
Lower Market Activity
The company has less investor interest, with a 20-day turnover ratio of -0.96.

BioNexus Gene Lab Corp News

More news coming soon, stay tuned...

Financial Indicators

EPS

No Data

Total revenue

No Data

BioNexus Gene Lab Corp Info

BioNexus Gene Lab Corporation is a Malaysia-based company, which provides ribonucleic acid (RNA)-based genomic diagnostics. The Company provides a molecular lab that is focused on the application of functional genomics to enable early detection of infectious diseases and cancers. The Company operates in the biochemical industry segment through its two Malaysian subsidiaries, MRNA Scientific Malaysia and Chemrex. MRNA Scientific Malaysia owns algorithm software, technology, and know-how related to the detection of common diseases through blood analysis which the Company uses in its business. The Company's non-invasive blood screening tests analyze changes in RNA to coronavirus, dengue, human immunodeficiency virus (HIV), human papillomavirus (HPV) and the risk potentiality of cancer diseases. Chemrex is a wholesaler of industrial chemicals for the manufacture of industrial, medical, appliance, aero, automotive, mechanical and electronic industries in Asean region.
Ticker SymbolBGLC
CompanyBioNexus Gene Lab Corp
CEOMr. Lee Su-Leng Tan
Websitehttps://www.bionexusgenelab.com/
KeyAI